Search

Search Results

• Serum interleukin-6 concentration in patients with pemphigus

  Thai Van Thanh Le, Anh Tuan Ngo, Quoc Hung Ta, The Bich Thanh Vuong

  01-02-2024

  https://doi.org/10.4081/dr.2024.9868

  934

  PDF: 482

  HTML: 29
• 

  Autoinflammatory diseases: what is behind them and what is new?

  Michele Maalouly, Serena Saade, Mazen Kurban

  29-12-2022

  https://doi.org/10.4081/dr.2023.9625

  1899

  PDF: 594

  HTML: 166

• Analysis of interleukin 7 and platelet-derived growth factor-BB mRNA expression as potential markers in erythema nodosum leprosum

  Fitri Kadarsih Banjar, Farida Tabri, Sri Vitayani Muchtar, Mochammad Hatta, Khaeruddin Djawad, Farida Ilyas, Sitti Musafirah, Muhammad Nasrum Massi, Agussalim Bukhari, Andi Alfian Zainuddin

  12-09-2023

  https://doi.org/10.4081/dr.2023.9773

  994

  PDF: 492

  HTML: 28

• Increased serum interleukin-31 levels correlate with pruritus in psoriatic patients: a cross-sectional study in Vietnam

  Chuyen Thi Hong Nguyen, Liem Viet Quoc Tran

  27-11-2024

  https://doi.org/10.4081/dr.2024.10090

  897

  PDF: 436

  HTML: 33
• 

  Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata

  Trang Thi Thuy Le, Thang Tat Nguyen, Chuyen Thi Hong Nguyen, Hao Trong Nguyen, Trung The Van

  27-10-2021

  https://doi.org/10.4081/dr.2021.9398

  3186

  PDF: 622

  HTML: 17

• Neutrophilic urticarial dermatosis without systemic disease: case report

  Sukaina Al Haddad, Abdulrahman Alfawzan, Maisa Alfalah , Manea Alharbi

  30-01-2024

  https://doi.org/10.4081/dr.2024.9756

  1022

  PDF: 760

  HTML: 61
• 

  Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

  Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  19-05-2023

  https://doi.org/10.4081/dr.2023.9692

  1172

  PDF: 577

  HTML: 28
• 

  Atopic dermatitis: a brief review of recent advances in its management

  Sultan Daghafak Alenazi

  23-05-2023

  https://doi.org/10.4081/dr.2023.9678

  2530

  PDF: 1454

  HTML: 128
• 

  Exploring valrubicin’s effect on Propionibacterium acnes-induced skin inflammation in vitro and in vivo

  Louise Rottboell, Sarah de Foenss, Kenneth Thomsen, Helle Christiansen, Stine M. Andersen, Thomas N. Dam, Cecilia Rosada, Karin Stenderup

  17-12-2015

  https://doi.org/10.4081/dr.2015.6246

  3241

  PDF: 979

  HTML: 766
• 

  Implications of interleukin-17 in psoriatic lesions as Koebner phenomenon caused by recurrent occupational burns

  Ayumi Sato, Takeshi Fukumoto, Ai Yoshioka, Chikako Nishigori

  27-10-2022

  https://doi.org/10.4081/dr.2022.9567

  1039

  PDF: 542

  HTML: 22
• 

  Erythrodermic psoriasis improved by tildrakizumab

  Giampaolo Trevisan, Lerica Germi, Luigi Naldi

  23-11-2022

  https://doi.org/10.4081/dr.2022.9448

  1374

  PDF: 642

  HTML: 29

• Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

  Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  12-11-2024

  https://doi.org/10.4081/dr.2024.10080

  1387

  PDF: 757

  HTML: 50

• Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

  Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

  13-09-2023

  https://doi.org/10.4081/dr.2023.9839

  2867

  PDF: 1015

  HTML: 40

• Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

  Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo

  30-05-2025

  https://doi.org/10.4081/dr.2025.10414

  900

  PDF: 475

  HTML: 54
• 

  Immunohistochemical expression of interleukin β in papule biopsies from patients with acne vulgaris

  Le Thai Van Thanh, Le Vi Anh, Tran Huong Giang, Ta Quoc Hung, Van The Trung, Nguyen Lam Vuong

  17-03-2022

  https://doi.org/10.4081/dr.2022.9444

  1244

  PDF: 627

  HTML: 31
• 

  Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

  Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza

  21-11-2022

  https://doi.org/10.4081/dr.2022.9447

  1433

  PDF: 432

  HTML: 54
• 

  Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

  Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

  22-05-2023

  https://doi.org/10.4081/dr.2023.9630

  1123

  PDF: 593

  HTML: 98
• 

  Telangiectasia Macularis Eruptiva Perstans: more than skin deep

  Casey E. Watkins, Winston B. Bokor, Stuart Leicht, George Youngberg, Guha Krishnaswamy

  e12

  29-07-2011

  https://doi.org/10.4081/dr.2011.e12

  11814

  PDF: 2262

  HTML: 2307

• Mendelian randomization analysis of the causal relationship between immune cells and keloid

  Jingwen Zou, Pengkhun Nov, Kunpeng Du

  23-10-2024

  https://doi.org/10.4081/dr.2024.10106

  891

  PDF: 468

  SUPPLEMENTARY MATERIAL: 164

  HTML: 23
• 

  The role of protein-53 amyloid in determining the aggressiveness of basal cell carcinoma regulated by interleukin-6, myeloid cell leukemia-1 and basic fibroblast growth factor

  Prasetyadi Mawardi, Handono Kalim, Kusworini Handono Kalim, Loeki Enggar Fitri, Karyono Mintarjo, Ambar Mudigdo, Oyong Oyong, Brian Wasita

  29-03-2019

  https://doi.org/10.4081/dr.2019.8012

  1338

  PDF: 535

• Refractory pityriasis rubra pilaris treated with abrocitinib

  Filip Rob

  09-01-2025

  https://doi.org/10.4081/dr.2025.10105

  521

  PDF: 331

  HTML: 27

• 67 | LEBRIKIZUMAB FOR PAEDIATRIC PATIENTS AGED ≥6 MONTHS WITH MODERATE-TO-SEVERE AD: PHASE 3 ADORABLE-1 WEEK-16 RESULTS L. Stingeni¹, L. Eichenfield², J. Ornelas³, V. Prajapati⁴, C. Yang⁵, A. Tanaka⁶, S. Weidinger⁷, C. Flohr⁸, E. Swanson⁹, L. Martin¹⁰, S. Daveiga¹¹, R. Gontijo Lima¹¹, H. Elmaraghy¹¹, E. Pierce¹¹, P. Sen¹¹, G. Gallo¹¹, M. Piruzeli¹¹, A. Larkin¹¹, M. Grau¹², Y. Mihaylov¹², A. Paller¹³ | ¹Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; ²Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California, USA; ³Department of Dermatology, Integrative Skin Science and Research, Sacramento, California, USA; ⁴Dermatology Research Institute, Skin Health & Wellness Centre, Probity Medical Research, and University of Calgary, Calgary, Canada; ⁵Chang Gung University College of Medicine, Taoyuan, Taiwan; ⁶Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; ⁷Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Lübeck, Germany; ⁸Department of Dermatology and Population Health Sciences, King’s College London, UK; ⁹Ada West Dermatology, St Luke’s Children’s Hospital Idaho, USA; ¹⁰School of Clinical Medicine, UNSW Sydney & Dermatology Department, Sydney Children’s Hospital, Sydney, Australia; ¹¹Eli Lilly and Company, Indianapolis, Indiana, USA; ¹²Almirall R&D, S.A., Barcelona, Spain; ¹³Dermatology and Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11114

  129

  PDF: 65

• Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series

  Andrea D'Arino, Maria Concetta Fargnoli, Pasquale Frascione, Chiara Assorgi, Annunziata Dattola, Viviana Lora, Matteo Megna, Flavia Pigliacelli, Emanuele Vagnozzi, Diego Orsini

  30-07-2025

  https://doi.org/10.4081/dr.2025.10379

  592

  PDF: 407

  HTML: 15

• Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

  Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

  11-11-2024

  https://doi.org/10.4081/dr.2024.10140

  1097

  PDF: 581

  SUPPLEMENTARY MATERIAL: 189

  HTML: 24
• 

  Improvement of atopic dermatitis and alopecia universalis with dupilumab

  Lama Alotaibi, Abdulrahman Alfawzan, Raghad Alharthi, Afaf Al sheikh

  28-12-2021

  https://doi.org/10.4081/dr.2022.9359

  1420

  PDF: 593

  HTML: 55